MPN Advances Day 2017 | Diagnosis, classification and treatment of systemic mastocytosis
Systemic mastocytosis, though a rare disease, is more common than clinicians may think and diagnosis of the condition can often be missed. In this insightful interview, Deepti Radia, MBBS, MRCPI, FRCPath, of Guy’s and St Thomas’ Hospital NHS Foundation Trust, London UK, details the latest updates in the field, such as the new WHO classification guidelines for diagnosis and classification. Dr Radia also discusses the treatment options for this condition, which often consists of symptomatic treatment, but in cases of aggressive systemic mastocytosis there are now targeted treatments available, such as midostaurin, BLU-285 and DCC-2618. This video was recorded at the Myeloproliferative Neoplasms Advances Day 2017, London, UK.
Get great new content delivered to your inboxSign up